Cargando…

Evaluation of Racial Disparities in Hospice Use and End-of-Life Treatment Intensity in the REGARDS Cohort

IMPORTANCE: Although hospice use is increasing and patients in the US are increasingly dying at home, racial disparities in treatment intensity at the end of life, including hospice use, remain. OBJECTIVE: To examine differences between Black and White patients in end-of-life care in a population sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ornstein, Katherine A., Roth, David L., Huang, Jin, Levitan, Emily B., Rhodes, J. David, Fabius, Chanee D., Safford, Monika M., Sheehan, Orla C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445597/
https://www.ncbi.nlm.nih.gov/pubmed/32833020
http://dx.doi.org/10.1001/jamanetworkopen.2020.14639
_version_ 1783574016204734464
author Ornstein, Katherine A.
Roth, David L.
Huang, Jin
Levitan, Emily B.
Rhodes, J. David
Fabius, Chanee D.
Safford, Monika M.
Sheehan, Orla C.
author_facet Ornstein, Katherine A.
Roth, David L.
Huang, Jin
Levitan, Emily B.
Rhodes, J. David
Fabius, Chanee D.
Safford, Monika M.
Sheehan, Orla C.
author_sort Ornstein, Katherine A.
collection PubMed
description IMPORTANCE: Although hospice use is increasing and patients in the US are increasingly dying at home, racial disparities in treatment intensity at the end of life, including hospice use, remain. OBJECTIVE: To examine differences between Black and White patients in end-of-life care in a population sample with well-characterized causes of death. DESIGN, SETTING, AND PARTICIPANTS: This study used data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, an ongoing population-based cohort study with enrollment between January 25, 2003, and October 3, 2007, with linkage to Medicare claims data. Multivariable logistic regression models were used to examine racial and regional differences in end-of-life outcomes and in stroke mortality among 1212 participants with fee-for-service Medicare who died between January 1, 2013, and December 31, 2015, owing to natural causes and excluding sudden death, with oversampling of Black individuals and residents of Southeastern states in the United States. Initial analyses were conducted in March 2019, and final primary analyses were conducted in February 2020. MAIN OUTCOMES AND MEASURES: The primary outcomes of interest were hospice use of 3 or more days in the last 6 months of life derived from Medicare claims files. Other outcomes included multiple hospitalizations, emergency department visits, and use of intensive procedures in the last 6 months of life. Cause of death was adjudicated by an expert panel of clinicians using death certificates, proxy interviews, autopsy reports, and medical records. RESULTS: The sample consisted of 1212 participants (630 men [52.0%]; 378 Black individuals [31.2%]; mean [SD] age at death, 81.0 [8.6] years) of 2542 total deaths. Black decedents were less likely than White decedents to use hospice for 3 or more days (132 of 378 [34.9%] vs 385 of 834 [46.2%]; P < .001). After stratification by cause of death, substantial racial differences in treatment intensity and service use were found among persons who died of cardiovascular disease but not among patients who died of cancer. In analyses adjusted for cause of death (dementia, cancer, cardiovascular disease, and other) and clinical and demographic variables, Black decedents were significantly less likely to use 3 or more days of hospice (odds ratio [OR], 0.72; 95% CI, 0.54-0.96) and were more likely to have multiple emergency department visits (OR, 1.35; 95% CI, 1.01-1.80) and hospitalizations (OR, 1.39; 95% CI, 1.02-1.89) and undergo intensive treatment (OR, 1.94; 95% CI, 1.40-2.70) in the last 6 months of life compared with White decedents. CONCLUSIONS AND RELEVANCE: Despite the increase in the use of hospice care in recent decades, racial disparities in the use of hospice remain, especially for noncancer deaths. More research is required to better understand racial disparities in access to and quality of end-of-life care.
format Online
Article
Text
id pubmed-7445597
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-74455972020-09-02 Evaluation of Racial Disparities in Hospice Use and End-of-Life Treatment Intensity in the REGARDS Cohort Ornstein, Katherine A. Roth, David L. Huang, Jin Levitan, Emily B. Rhodes, J. David Fabius, Chanee D. Safford, Monika M. Sheehan, Orla C. JAMA Netw Open Original Investigation IMPORTANCE: Although hospice use is increasing and patients in the US are increasingly dying at home, racial disparities in treatment intensity at the end of life, including hospice use, remain. OBJECTIVE: To examine differences between Black and White patients in end-of-life care in a population sample with well-characterized causes of death. DESIGN, SETTING, AND PARTICIPANTS: This study used data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, an ongoing population-based cohort study with enrollment between January 25, 2003, and October 3, 2007, with linkage to Medicare claims data. Multivariable logistic regression models were used to examine racial and regional differences in end-of-life outcomes and in stroke mortality among 1212 participants with fee-for-service Medicare who died between January 1, 2013, and December 31, 2015, owing to natural causes and excluding sudden death, with oversampling of Black individuals and residents of Southeastern states in the United States. Initial analyses were conducted in March 2019, and final primary analyses were conducted in February 2020. MAIN OUTCOMES AND MEASURES: The primary outcomes of interest were hospice use of 3 or more days in the last 6 months of life derived from Medicare claims files. Other outcomes included multiple hospitalizations, emergency department visits, and use of intensive procedures in the last 6 months of life. Cause of death was adjudicated by an expert panel of clinicians using death certificates, proxy interviews, autopsy reports, and medical records. RESULTS: The sample consisted of 1212 participants (630 men [52.0%]; 378 Black individuals [31.2%]; mean [SD] age at death, 81.0 [8.6] years) of 2542 total deaths. Black decedents were less likely than White decedents to use hospice for 3 or more days (132 of 378 [34.9%] vs 385 of 834 [46.2%]; P < .001). After stratification by cause of death, substantial racial differences in treatment intensity and service use were found among persons who died of cardiovascular disease but not among patients who died of cancer. In analyses adjusted for cause of death (dementia, cancer, cardiovascular disease, and other) and clinical and demographic variables, Black decedents were significantly less likely to use 3 or more days of hospice (odds ratio [OR], 0.72; 95% CI, 0.54-0.96) and were more likely to have multiple emergency department visits (OR, 1.35; 95% CI, 1.01-1.80) and hospitalizations (OR, 1.39; 95% CI, 1.02-1.89) and undergo intensive treatment (OR, 1.94; 95% CI, 1.40-2.70) in the last 6 months of life compared with White decedents. CONCLUSIONS AND RELEVANCE: Despite the increase in the use of hospice care in recent decades, racial disparities in the use of hospice remain, especially for noncancer deaths. More research is required to better understand racial disparities in access to and quality of end-of-life care. American Medical Association 2020-08-24 /pmc/articles/PMC7445597/ /pubmed/32833020 http://dx.doi.org/10.1001/jamanetworkopen.2020.14639 Text en Copyright 2020 Ornstein KA et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Ornstein, Katherine A.
Roth, David L.
Huang, Jin
Levitan, Emily B.
Rhodes, J. David
Fabius, Chanee D.
Safford, Monika M.
Sheehan, Orla C.
Evaluation of Racial Disparities in Hospice Use and End-of-Life Treatment Intensity in the REGARDS Cohort
title Evaluation of Racial Disparities in Hospice Use and End-of-Life Treatment Intensity in the REGARDS Cohort
title_full Evaluation of Racial Disparities in Hospice Use and End-of-Life Treatment Intensity in the REGARDS Cohort
title_fullStr Evaluation of Racial Disparities in Hospice Use and End-of-Life Treatment Intensity in the REGARDS Cohort
title_full_unstemmed Evaluation of Racial Disparities in Hospice Use and End-of-Life Treatment Intensity in the REGARDS Cohort
title_short Evaluation of Racial Disparities in Hospice Use and End-of-Life Treatment Intensity in the REGARDS Cohort
title_sort evaluation of racial disparities in hospice use and end-of-life treatment intensity in the regards cohort
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445597/
https://www.ncbi.nlm.nih.gov/pubmed/32833020
http://dx.doi.org/10.1001/jamanetworkopen.2020.14639
work_keys_str_mv AT ornsteinkatherinea evaluationofracialdisparitiesinhospiceuseandendoflifetreatmentintensityintheregardscohort
AT rothdavidl evaluationofracialdisparitiesinhospiceuseandendoflifetreatmentintensityintheregardscohort
AT huangjin evaluationofracialdisparitiesinhospiceuseandendoflifetreatmentintensityintheregardscohort
AT levitanemilyb evaluationofracialdisparitiesinhospiceuseandendoflifetreatmentintensityintheregardscohort
AT rhodesjdavid evaluationofracialdisparitiesinhospiceuseandendoflifetreatmentintensityintheregardscohort
AT fabiuschaneed evaluationofracialdisparitiesinhospiceuseandendoflifetreatmentintensityintheregardscohort
AT saffordmonikam evaluationofracialdisparitiesinhospiceuseandendoflifetreatmentintensityintheregardscohort
AT sheehanorlac evaluationofracialdisparitiesinhospiceuseandendoflifetreatmentintensityintheregardscohort